Notable insider buying and selling activity across public companies.
Tracking and analysis of reported insider transactions, including executive and director buying or selling. Insider activity can offer insight into internal confidence, valuation perceptions, and potential inflection points.
12,062 total articles
Claire Rotshten, Kaltura Inc.'s Executive Vice President of Finance, purchased 10,000 shares on March 23, 2026, at $1.29 per share. The transaction coincides with a recent quarterly earnings beat and a stock trading near its 52-week low. Analysts have forecast profitability for FY2026 at $0.03 per share.
An officer at Kaltura Inc. purchased 5,000 shares in an open-market transaction on March 23, 2026, paying $1.28 per share for a $6,400 outlay. The buy follows strong fourth-quarter 2025 results and comes as the stock trades near $1.25, down roughly 26% over the last six months. Analysts forecast a return to profitability this year and have set pric…
Horizon Kinetics Asset Management LLC, identified as a 10% holder of Texas Pacific Land Corp (TPL), reported a single-share purchase on March 24, 2026 at $534.94 per share, listed as totaling $534. The trade comes while TPL is trading near its 52-week high and following a quarter with earnings and revenue narrowly short of forecasts. Investment res…
Edward Rizzuti, Executive Vice President of Alamo Group (ALG), sold 600 shares on March 24, 2026, for $170.925 per share, generating proceeds of $102,555. The transaction was reported on a Form 4 filed with the Securities and Exchange Commission. The sale occurs while Alamo Group shares trade close to their 52-week low of $156.29 and following a fo…
Patrizio Vinciarelli, Vicor Corp chairman and CEO, sold 23,179 shares of Vicor stock on March 24, 2026, for proceeds totaling $4,170,596. The trades were placed under a Rule 10b5-1 plan adopted November 3, 2025. After the sales, Vinciarelli holds 9,034,984 shares directly and 171,125 indirectly as trustee. Independent analysis cited in the report i…
NMI Holdings Executive Chairman Bradley M. Shuster reported the sale of 18,953 common shares on March 24, 2026, generating $707,832, and exercised options the prior day to acquire 55,156 shares. The company also posted Q4 2025 results that beat consensus on both EPS and revenue, while the stock trades close to a published fair value estimate.
Jorey Chernett, who holds a 10% stake in Airsculpt Technologies, made a mixed set of transactions on March 23, 2026, purchasing common shares and selling and acquiring multiple call option positions. The trading coincides with heightened share-price volatility and a short delay in the company’s Form 10-K filing as AirSculpt works to finalize inter-…
John Farahi, chief executive of Monarch Casino & Resort Inc, sold 3,000 shares of common stock in two Form 4-reported transactions on March 10 and March 16, 2026, generating proceeds of $295,430. The company reported fourth-quarter adjusted EBITDA that beat estimates by 6%, while Stifel maintained a Hold rating and a $97.00 price target. Farahi ret…
Leon J. Topalian, chair and CEO of Nucor Corporation (NUE), sold $1.86 million of company shares on March 23, 2026, across two priced transactions and a separate disposal recorded at zero value. The transactions were disclosed on a Form 4 filing. Nucor is trading near its fair value, has maintained dividend payments for 54 consecutive years, and is…
Oliver Simpson, Executive Vice President and Chief Commercial Officer of Excelerate Energy, sold 6,000 Class A shares on March 20, 2026 under a pre-established Rule 10b5-1 trading plan. The transaction totaled $204,900 at a weighted average price of $34.15. The company reported fourth-quarter 2025 results with revenue beating expectations while EPS…
FatPipe Inc/UT director Bhaskar Ragula acquired 20,000 common shares at $1.45 on March 3, 2026, a transaction valued at $29,000, according to a Form 4 filed with the Securities and Exchange Commission. Following the purchase Ragula directly holds 2,305,766 shares. The stock trades at $1.85 after falling more than 85% from its 52-week high of $23.27…
Stephen L. Sabba, a member of Ligand Pharmaceuticals' board, sold 1,000 shares on March 23, 2026, for $207,872. The transaction left him with 32,793 shares. The sale occurs while Ligand reports robust fourth-quarter and full-year 2025 results and amid analyst price-target increases and reiterated Buy ratings.
Richard Bloxam, CEO of Capital Markets Services at Jones Lang LaSalle (NYSE: JLL), sold 5,440 shares of common stock on March 24, 2026, for approximately $1.6 million at $296.9415 per share. The transaction was carried out under a Rule 10b5-1(c) plan adopted by his spouse on December 23, 2025, and following the sale the spouse holds no JLL shares. …
Christopher D. Clark, president of Royce Small-Cap Trust, acquired 4,500 shares on March 24, 2026 for $16.69 apiece, a transaction valued at $75,105. After the purchase Clark directly holds 47,235 shares. The trust currently yields 7.2%, has paid dividends for 40 consecutive years, and trades at $16.86 with a $2.01 billion market capitalization and…
Japan Post Holdings Co., Ltd. disposed of 15,000 shares of AFLAC Inc. common stock on March 23, 2026, in transactions totaling about $1.6 million, according to a Form 4 filing. The sales occurred in two tranches at weighted average prices of $106.78 and $107.36. After the trades, Japan Post directly held 52,046,800 AFLAC shares. AFLAC's recent four…
Jorey Chernett, who holds a 10% stake in Oncology Institute, Inc. (NASDAQ: TOI), acquired 125,000 shares on March 24, 2026, at a weighted average price of $3.11 per share, for a total of $388,750. The purchase brings Chernett's direct holdings to 10,401,929 shares. The transaction occurred amid a 13% decline in the stock over the prior week, althou…
Kaltura INC Chief Executive Officer Ron Yekutiel purchased 40,000 shares of common stock on March 24, 2026, spending $49,568 on shares priced between $1.20 and $1.29. The transaction comes as Kaltura’s stock has fallen 44% over the last year. The company also reported Q4 2025 results that exceeded expectations, delivering EPS of $0.03 versus a $0.0…
A-6684 Ltd., an entity holding roughly 10% of Tofutti Brands Inc., purchased 5,000 common shares on March 23, 2026, at $0.70 per share for a total of $3,500. After the trade the affiliated entities controlled 702,100 shares. The stock has shown recent strength, trading at $0.78 and up 12% over the past week; InvestingPro data notes the company repo…
Ormat Technologies' General Counsel, Chief Compliance Officer, and Corporate Secretary Jessica Woelfel completed a sell-to-cover transaction on March 24, 2026, disposing of 136 shares at $107.79 each for $14,659 to satisfy tax withholding on RSUs that vested March 21, 2026. The filings also show concurrent option exercises and equity deliveries, wh…
Foxx Development Holdings Inc. disclosed an insider sale by Executive Vice President Cui Haitao and the board-level appointment of Michelle Jie Shen. Cui sold 3,291 shares on March 20, 2026, for $4.54 per share, netting $14,941 and leaving him with 133,307 shares in total. Separately, Shen was elected to the board on December 22, 2025, with a $60,0…
Reliance Global Group Chief Financial Officer Joel Markovits sold 127,562 shares of common stock on March 24, 2026, at $0.2055 per share, a transaction totaling $26,213. The sale occurred while the stock trades near its 52-week low and the company reports ongoing strategic and financial adjustments, including an increased stake in Enquantum Ltd. an…
RenovoRx Chief Executive Officer Shaun Bagai, through The Bagai Family Trust, acquired 24,300 shares of RenovoRx common stock on March 20, 2026, in a transaction reported with a total value of $0. The trust also received 12,150 warrants that are immediately exercisable at $1.9326 and carry an expiration tied to March 30, 2029, or an operational sal…
RenovoRx, Inc. (NASDAQ: RNXT) disclosed that Chief Financial Officer Mark Voll purchased 97,200 shares of common stock and 48,600 warrants in a transaction dated March 20, 2026. The warrants carry a $1.9326 exercise price, are exercisable immediately and include standard expiration and revenue-triggered acceleration terms. The securities were acqui…
Ramaco Resources director Bryan H. Lawrence sold a total of $8.2 million of Class A common stock in a series of transactions executed March 20, March 23 and March 24, 2026. The trades, which amounted to 600,000 shares sold in nine transactions, were completed at prices between $13.4811 and $14.0004. The sales occurred amid significant share-price s…
RenovoRx director Laurence Marton purchased 9,720 common shares and 4,860 warrants in a private placement worth $10,000. The warrants carry a $1.9326 exercise price, are exercisable immediately, and expire on March 30, 2029 or 30 days after the company reports $1.5 million in product sales in a calendar quarter. The transaction comes as RenovoRx re…
